Product information
From Health Canada
Current status:
Marketed
Current status date:
2018-06-20
Original market date: See footnote 1
2018-06-20
Product name:
ANTICOAGULANT CITRATE DEXTROSE SOLUTION USP (ACD) FORMULA A
Description:
FOR USE ONLY WITH APHERESIS DEVICES
DIN:
02469731 Electronic product monograph is not available
Company:
TERUMO BCT, INC.
10811 W Collins Ave
Lakewood
Colorado
United States
80215
Class:
Human
Dosage form(s):
Solution
Route(s) of administration:
0-Unassigned
Number of active ingredient(s):
3
Schedule(s):
Ethical
American Hospital Formulary Service (AHFS): See footnote 3
20:12.04.92
Anatomical Therapeutic Chemical (ATC): See footnote 4
V07AC BLOOD TRANSFUSION, AUXILIARY PRODUCTS
Active ingredient group (AIG) number:See footnote5
0359691001
Active ingredient(s) | Strength |
---|---|
CITRIC ACID MONOHYDRATE | 0.8 G / 100 ML |
DEXTROSE | 2.45 G / 100 ML |
SODIUM CITRATE DIHYDRATE | 2.2 G / 100 ML |